+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type , By End User (Dermatological Clinics, Hospitals, and Others), By Disorder Type (Melasma, Age Spot, and Others). By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 117 Pages
  • March 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953553
The LAMEA Hyperpigmentation Treatment Market would witness market growth of 10.7% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA Hyperpigmentation Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $191.9 million by 2030. The Argentina market is showcasing a CAGR of 11.3% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.4% during (2023 - 2030).



There is a growing trend toward incorporating botanical and natural ingredients in hyperpigmentation treatments. Consumers increasingly seek products with plant-based extracts known for their skin-brightening properties, such as licorice root, arbutin, kojic acid, and niacinamide. Natural ingredients are perceived as gentler alternatives to certain synthetic compounds and align with the broader consumer trend toward clean and sustainable beauty. Products containing botanical extracts are often favored for their potential to address hyperpigmentation without irritating.

As individuals age, there is a heightened focus on overall skin health, leading to a proactive approach to seeking professional skincare solutions. The increased emphasis on skin health among the aging population drives the demand for hyperpigmentation treatments as individuals prioritize interventions that contribute to healthy and radiant skin.

As per the International Trade Administration, the United Arab Emirates leads the Gulf Cooperation Council in eCommerce sales, which surged by 53% in 2020 to a record $3.9 billion, or 10% of overall retail sales. The Dubai Chamber of Commerce and Industry signifies that eCommerce will develop $8 billion in sales by 2025 as the UAE region has nearly 100% internet and mobile phone penetration. Thus, due to these aspects, the hyperpigmentation treatment market will expand across the LAMEA region in upcoming years.

Based on Treatment Type, the market is segmented into Topical Agent, Photo Therapy, and Microdermabrasion. Based on End User, the market is segmented into Dermatological Clinics, Hospitals, and Others. Based on Disorder Type, the market is segmented into Melasma, Age Spot, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oréal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

Market Report Segmentation

By Treatment Type
  • Topical Agent
  • Photo Therapy
  • Microdermabrasion
By End User
  • Dermatological Clinics
  • Hospitals
  • Others
By Disorder Type
  • Melasma
  • Age Spot
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Hyperpigmentation Treatment Market, by Treatment Type
1.4.2 LAMEA Hyperpigmentation Treatment Market, by End User
1.4.3 LAMEA Hyperpigmentation Treatment Market, by Disorder Type
1.4.4 LAMEA Hyperpigmentation Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA Hyperpigmentation Treatment Market by Treatment Type
4.1 LAMEA Topical Agent Market by Country
4.2 LAMEA Photo Therapy Market by Country
4.3 LAMEA Microdermabrasion Market by Country
Chapter 5. LAMEA Hyperpigmentation Treatment Market by End User
5.1 LAMEA Dermatological Clinics Market by Country
5.2 LAMEA Hospitals Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Hyperpigmentation Treatment Market by Disorder Type
6.1 LAMEA Melasma Market by Country
6.2 LAMEA Age Spot Market by Country
6.3 LAMEA Others Market by Country
Chapter 7. LAMEA Hyperpigmentation Treatment Market by Country
7.1 Brazil Hyperpigmentation Treatment Market
7.1.1 Brazil Hyperpigmentation Treatment Market by Treatment Type
7.1.2 Brazil Hyperpigmentation Treatment Market by End User
7.1.3 Brazil Hyperpigmentation Treatment Market by Disorder Type
7.2 Argentina Hyperpigmentation Treatment Market
7.2.1 Argentina Hyperpigmentation Treatment Market by Treatment Type
7.2.2 Argentina Hyperpigmentation Treatment Market by End User
7.2.3 Argentina Hyperpigmentation Treatment Market by Disorder Type
7.3 UAE Hyperpigmentation Treatment Market
7.3.1 UAE Hyperpigmentation Treatment Market by Treatment Type
7.3.2 UAE Hyperpigmentation Treatment Market by End User
7.3.3 UAE Hyperpigmentation Treatment Market by Disorder Type
7.4 Saudi Arabia Hyperpigmentation Treatment Market
7.4.1 Saudi Arabia Hyperpigmentation Treatment Market by Treatment Type
7.4.2 Saudi Arabia Hyperpigmentation Treatment Market by End User
7.4.3 Saudi Arabia Hyperpigmentation Treatment Market by Disorder Type
7.5 South Africa Hyperpigmentation Treatment Market
7.5.1 South Africa Hyperpigmentation Treatment Market by Treatment Type
7.5.2 South Africa Hyperpigmentation Treatment Market by End User
7.5.3 South Africa Hyperpigmentation Treatment Market by Disorder Type
7.6 Nigeria Hyperpigmentation Treatment Market
7.6.1 Nigeria Hyperpigmentation Treatment Market by Treatment Type
7.6.2 Nigeria Hyperpigmentation Treatment Market by End User
7.6.3 Nigeria Hyperpigmentation Treatment Market by Disorder Type
7.7 Rest of LAMEA Hyperpigmentation Treatment Market
7.7.1 Rest of LAMEA Hyperpigmentation Treatment Market by Treatment Type
7.7.2 Rest of LAMEA Hyperpigmentation Treatment Market by End User
7.7.3 Rest of LAMEA Hyperpigmentation Treatment Market by Disorder Type
Chapter 8. Company Profiles
8.1 Vivier Pharma Inc.
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Pierre Fabre S.A
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.3 SWOT Analysis
8.3 Aerolase
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 L'Oréal S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.5 SWOT Analysis
8.5 The Procter & Gamble Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Galderma S.A.
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 CP Skin Health Group, Inc. (The Colgate Palmolive Company)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Trophy Skin Products LLC
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. Episciences, Inc.
8.10.1 Company Overview
8.10.2 SWOT Analysis

Companies Mentioned

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oréal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

Methodology

Loading
LOADING...